[New developments in the field of bronchospasmolytics].
D000420:Albuterol / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002976:Clenbuterol / Q000627:therapeutic use; D005280:Fenoterol / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D001993:Bronchodilator Agents; D005938:Glucocorticoids; D010276:Parasympatholytics; D010726:Phosphodiesterase Inhibitors; D013566:Sympathomimetics; D005280:Fenoterol; D000628:Aminophylline; D013806:Theophylline; D013726:Terbutaline; D000420:Albuterol; D002976:Clenbuterol
Nuovi sviluppi nel campo dei broncospasmolitici